These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 16913421)

  • 1. The role of conformational domain lability of fibrinogen molecule in the processes of fibrin formation and fibrinolysis.
    Rozenfel'd MA; Leonova VB; Biryukova MI
    Dokl Biochem Biophys; 2006; 408():165-8. PubMed ID: 16913421
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effect of "aging" of fibrinogen molecule on the structure and properties of fibrin gel].
    Rozenfel'd MA; Leonova VB; Biriukova MI
    Izv Akad Nauk Ser Biol; 2007; (4):394-401. PubMed ID: 17966900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of fibrin degradation products on fibrinolytic process.
    Yatsenko TA; Rybachuk VM; Yusova OI; Kharchenko SM; Grinenko TV
    Ukr Biochem J; 2016; 88(2):16-24. PubMed ID: 29227597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conversion of fibrinogen to fibrin: mechanism of exposure of tPA- and plasminogen-binding sites.
    Yakovlev S; Makogonenko E; Kurochkina N; Nieuwenhuizen W; Ingham K; Medved L
    Biochemistry; 2000 Dec; 39(51):15730-41. PubMed ID: 11123898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of DL and DH degradation products in the reactions of the plasmin hydrolysis of fibrinogen and fibrin].
    Rozenfel'd MA; Leonova VB; Khavkina LS
    Izv Akad Nauk SSSR Biol; 1991; (3):334-42. PubMed ID: 1835465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inhibition of the process of Glu-plasminogen activation by tissue activator with fibrin, DDE-complex, and D-dimer using alpha-2-antiplasmin].
    Hrynenko TV; Zadorozhna MB; Platonova TM; Volkov HL
    Ukr Biokhim Zh (1999); 2005; 77(5):45-51. PubMed ID: 16846069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Influence of end products of plasmin-mediated hydrolysis of fibrinogen and fibrin (EF and Ef fragments) on fibrinogen cross-linking].
    Leonova VB; Rozenfel'd MA; Biriukova MI; Kostanova EA; Vasil'eva MV
    Izv Akad Nauk Ser Biol; 2002; (5):522-7. PubMed ID: 12400374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of low frequency ultrasound on some properties of fibrinogen and its plasminolysis.
    Cherniavsky EA; Strakha IS; Adzerikho IE; Shkumatov VM
    BMC Biochem; 2011 Nov; 12():60. PubMed ID: 22112213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic changes of fibrin architecture during fibrin formation and intrinsic fibrinolysis of fibrin-rich clots.
    Collet JP; Lesty C; Montalescot G; Weisel JW
    J Biol Chem; 2003 Jun; 278(24):21331-5. PubMed ID: 12642590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrinogen and factor XIII at the intersection of coagulation, fibrinolysis and inflammation.
    Hoppe B
    Thromb Haemost; 2014 Oct; 112(4):649-58. PubMed ID: 25182841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrin clot structure and mechanics associated with specific oxidation of methionine residues in fibrinogen.
    Weigandt KM; White N; Chung D; Ellingson E; Wang Y; Fu X; Pozzo DC
    Biophys J; 2012 Dec; 103(11):2399-407. PubMed ID: 23283239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probing the beta-chain hole of fibrinogen with synthetic peptides that differ at their amino termini.
    Doolittle RF; Pandi L
    Biochemistry; 2007 Sep; 46(35):10033-8. PubMed ID: 17688324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New structural and functional properties of fibrinogen and its early homologue, fragment X.
    Rozenfel'd MA; Kostanova EA; Vasil'eva MV; Leonova VB
    Dokl Biochem Biophys; 2001; 378():191-4. PubMed ID: 11712177
    [No Abstract]   [Full Text] [Related]  

  • 14. The structure of soluble fibrin oligomers.
    Rosenfeld MA; Leonova VB; Biryukova MI; Vasileva MV
    Dokl Biochem Biophys; 2011; 440():203-6. PubMed ID: 22095118
    [No Abstract]   [Full Text] [Related]  

  • 15. Immobilization of aprotinin to fibrinogen as a novel method for controlling degradation of fibrin gels.
    Smith JD; Chen A; Ernst LA; Waggoner AS; Campbell PG
    Bioconjug Chem; 2007; 18(3):695-701. PubMed ID: 17432824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrochemical processing of fibrinogen modified-graphite surfaces: effect on plasmin generation from adsorbed plasminogen.
    Alfonsi-Hourdin S; Longchamp S; Gallet O; Nigretto JM
    Biomaterials; 2006 Jan; 27(1):52-60. PubMed ID: 16029886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zinc promotes clot stability by accelerating clot formation and modifying fibrin structure.
    Henderson SJ; Xia J; Wu H; Stafford AR; Leslie BA; Fredenburgh JC; Weitz DA; Weitz JI
    Thromb Haemost; 2016 Mar; 115(3):533-42. PubMed ID: 26489782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Development and optimization of the methods for determining activity of plasminogen activator inhibitor-1 in plasma].
    Roka-Moĭia IaM; Zhernosiekov DD; Kondratiuk AS; Hrynenko TV
    Ukr Biokhim Zh (1999); 2013; 85(4):111-8. PubMed ID: 24319981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of inhibition of fibrinolysis and fibrinogenolysis by the end fibrinogen degradation products.
    Khavkina LS; Rozenfeld MA; Leonova VB
    Thromb Res; 1995 Apr; 78(2):173-87. PubMed ID: 7482434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions.
    Wu JH; Diamond SL
    Thromb Haemost; 1995 Aug; 74(2):711-7. PubMed ID: 8585011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.